RxDoctor Payments DataLook up a doctor →

Brian Weeks, MD

Otolaryngology · San Diego, CANPI 1639185234

Payments from drug & device makers

$1,563,483in general payments, 2019–2025

Across 1,197 payments — averaging $1306.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$808K
  • Livanova USA, Inc.$640K
  • Acclarent, Inc$59K
  • Medical Device Business Services, Inc.$17K
  • Neurent Medical Limited$14K
  • Acelrx Pharmaceuticals, Inc.$11K
  • plus $15K from 13 others
$73,953in research payments, 2019–2025

Across 3 payments — averaging $24,651 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Sanofi US Services Inc.$56K
  • Neurent Medical Limited$18K

What the payments were for

  • Consulting fees$817,17088%
  • Speaking & faculty fees$6,6501%
  • Travel & lodging$74,2138%
  • Food & beverage$25,5693%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,563,483 in reported general payments places this provider in the 95th percentile of 1,021 otolaryngology providers in California.

See all otolaryngology providers in California

Medicare billing

Part B allowed, 2024
$657,390
Medicare patients
455
Services billed
2,104

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl52$1,059
Fluticasone Propionate39$664
Ipratropium Bromide12$398
Methylprednisolone16$123
Mupirocin12$83
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$49

Paid to pharmacies, not to this prescriber.

Other otolaryngology in San Diego

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →